Enhancement of dissolution rate of atorvastatin calcium using solid dispersions by dropping method

International Journal of PharmTech Research

Volumn 3, Issue 2, 2011, Pages 652-659

  Lakshmi Narasaiah, V ^a   Jimidi, Bhaskar ^b   Goli, Venkateswarlu ^b   Kanakam, Vijaya Bhaskar ^b  

^a Dr Samuel George Institute of Pharmaceutical sciences   (India)

^b Venkateswara Institute of Pharmaceutical Sciences   (India)

Author keywords

Atorvastatin calcium; Dropping method and peg 4000 6000; Solid dispersions

Indexed keywords

ATORVASTATIN; MACROGOL 4000; MACROGOL 6000;

ARTICLE; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG PURITY; DRUG RELEASE; DRUG SOLUBILITY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IN VITRO STUDY; PH;

EID: 84856251917     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J. Pediatr. 2003,143 (1), 74-80.
2. M. Hite, S. Turner and C. Federici, Pharmaceutical Manufacturing and Packing Source, Part 1: Oral delivery of Poorly Soluble Drugs, summer 2003; www.scolr.com/lit/PMPS_2003_1.pdf.
3. A. H. Goldberg, M. Gibaldi and J. L. Kanig, Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures-I theoretical consideration and discussion of the literature, J. Pharm. Sci., 1965, 54, 1145-1148.
4. A. H. Goldberg, M. Gibaldi and J. L. Kanig, Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures - II - experimental evaluation of eutectic mixture: urea-acetaminophen system, J. Pharm. Sci. 1966, 55, 482-487.
5. A. H. Goldberg, M. Gibaldi, J. L. Kanig and M. Mayersohn, Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures - IV - chloramphenicol- urea system, J. Pharm. Sci., 1966, 55, 581-583.
6. D. Hoerter and J. B. Dressman, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract, Adv. Drug Del. Res., 1997, 25, 3-14.
7. B. C. Hancock and G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical system, J. Pharm. Sci., 1997, 86, 1-12.
8. T. Loftsson and M. E. Brewster, Pharmaceutical applications of cyclodextrins: Drug solubilization and stabilization, J. Pharm. Sci., 1996, 85, 1017-1025.
9. L. F. Huang and W. Q. Tong, Impact of solid state properties on developability assessment of drug candidates, Adv. Drug Del. Rev., 2004, 56, 321-334.
10. M. Pudipeddi, A. T. M. Serajuddin. Trends in solubility of polymorphs. J. Pharm. Sci., 2005, 94, 929-939.
11. D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water- soluble polymers, Int. J. Pharm., 2002, 231, 131-144.
12. W. L. Chiou, S. Riegelman. Pharmaceutical applications of solid dispersions. J. of Pharm. Sci., 1971, 60, 1281-1302.
13. K. Sekiguchi and N. Obi, Studies on absorption of eutectic mixtures - I. A comparison of the behavior of eutectic mixture of sulphathiazole and that of ordinary sulphathiazole in man, Chem. Pharm. Bull., 1961, 9, 866-872.
14. T. Tachibana and A. Nakamura, A method for preparing an aqueous colloidal dispersion of organic material by using water soluble polymers: dispersion of beta-carotene by polyvinylpyrrolidone, Kolloid-Z. Polym., 1965, 203, 130-133.
15. J. C. Price, Polyethylene Glycol, in Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, Washington 1994, 355-361.
16. T. Higuchi and K. Connors, Phase solubility techniques, Adv. Anal. Chem. Instrum., 1965, 4, 117-123.
17. N. Arunkumar, M. Deecaraman, C. Rani, K.P. Mohanraj, K. Venkates Kumar. Preparation And Solid State Characterization of Atorvastatin Nano-suspensions for Enhanced Solubility and Dissolution. International Journal of PharmTech Research, 2009, 1(4), 1725-1730.
18. Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975; 27(1):48-9.
19. P. Vijayalakshmi and V. Kusum Devi. Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design. Drug Development and Industrial Pharmacy, 2008, 34:33-45.
20. nd edition, 8.
21. K. G. Desai and C. Liu, Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions, Pharma. Dev. Tech., 2005, 10, 467-477.
22. Moreshwar P. Patil, Naresh J. Gaikwad. Preparation and characterization of gliclazide- polyethylene glycol 4000 solid dispersions. Acta Pharm. 2009, 59, 57-65.